Identifying Blood Biomarkers to Improve the Diagnosis of Stroke

Overview

Journal J R Coll Physicians Edinb

Publisher Sage Publications

Specialties General Medicine
History of Medicine
Medical Education

Date 2011 Jun 17

PMID 21677921

Citations 4

Authors

W Whiteley

Affiliations

Soon will be listed here.

Abstract

Blood biomarkers are useful for the management of many diseases and could be useful for doctors caring for stroke patients, if they accurately predicted a diagnosis or recurrence of stroke. In a series of studies, we systematically reviewed the blood biomarker literature in stroke, determined the performance of existing blood biomarkers for the diagnosis of stroke and examined the value of markers of inflammation to predict recurrent stroke and myocardial infarction.

Citing Articles

The Importance of Increased Serum GFAP and UCH-L1 Levels in Distinguishing Large Vessel from Small Vessel Occlusion in Acute Ischemic Stroke.

Kraljevic I, Sablic S, Marinovic Guic M, Budimir Mrsic D, Stula I, Dolic K Biomedicines. 2024; 12(3).

PMID: 38540221 PMC: 10968001. DOI: 10.3390/biomedicines12030608.

Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients.

Ren C, Kobeissy F, Alawieh A, Li N, Li N, Zibara K Sci Rep. 2016; 6:24588.

PMID: 27074724 PMC: 4830936. DOI: 10.1038/srep24588.

Optimal therapeutic dose and time window of picroside II in cerebral ischemic injury.

Liu G, Zhao L, Wang T, Zhang M, Pei H Neural Regen Res. 2014; 9(15):1437-45.

PMID: 25317155 PMC: 4192945. DOI: 10.4103/1673-5374.139460.

Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases.

Tjarnlund-Wolf A, Brogren H, Lo E, Wang X Stroke. 2012; 43(10):2833-9.

PMID: 22879095 PMC: 3712849. DOI: 10.1161/STROKEAHA.111.622217.